Intervention Review

Depot risperidone for schizophrenia

  1. Prakash Hosalli1,*,
  2. John M Davis2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 20 OCT 2003

Assessed as up-to-date: 13 AUG 2003

DOI: 10.1002/14651858.CD004161

How to Cite

Hosalli P, Davis JM. Depot risperidone for schizophrenia. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD004161. DOI: 10.1002/14651858.CD004161.

Author Information

  1. 1

    Seacroft Hospital, The Newsam Centre, Leeds, West Yorkshire, UK

  2. 2

    University of Illinois at Chicago, Chicago, USA

*Prakash Hosalli, The Newsam Centre, Seacroft Hospital, York Road, Leeds, West Yorkshire, LS14 6WB, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 OCT 2003


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.